FDA Warning Letter — Dexcowin Co. Ltd.
The FDA took a Warning Letter action against Dexcowin Co. Ltd. on Feb 20, 2018 (Geumcheon, South Korea). The action was issued by CDRH and concerns devices products. This facility has 5 or more recent FDA inspections on record.
Action details
- Facility
- Dexcowin Co. Ltd.
- Date
- Feb 20, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Center
- CDRH
- Location
- Geumcheon (South Korea)